Ignite Creation Date:
2025-12-25 @ 4:52 AM
Ignite Modification Date:
2026-04-24 @ 9:09 PM
Study NCT ID:
NCT01496118
Status:
COMPLETED
Last Update Posted:
2022-02-02
First Post:
2011-12-15
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of the Combination of Panobinostat and Carfilzomib in Patients With Relapsed/Refractory Multiple Myeloma
Sponsor:
SCRI Development Innovations, LLC
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
SCRI MM 27
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None